LNTH
Lantheus Holdings, Inc.NASDAQHealthcare$76.10+0.53%ClosedMarket Cap: $4.95B
As of 2026-04-06
Valuation
P/E (TTM)
21.21
PEG
—
P/B
4.57
P/S
3.20
EV/EBITDA
13.02
DCF Value
$696.92
FCF Yield
7.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
61.1%
Operating Margin
20.2%
Net Margin
15.2%
ROE
20.6%
ROA
10.5%
ROIC
12.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $406.8M | 59.2% | $77.2M | $54.1M | $0.82 | — |
| FY 2025 | $1.54B | 61.1% | $310.8M | $233.6M | $3.41 | — |
| Q3 2025 | $384.0M | 57.9% | $43.6M | $27.8M | $0.41 | — |
| Q2 2025 | $378.0M | 63.8% | $88.0M | $78.8M | $1.12 | — |
| Q1 2025 | $372.8M | 63.8% | $102.1M | $72.9M | $1.02 | — |
| Q4 2024 | $391.1M | 63.5% | $113.9M | $-11.8M | $-0.17 | — |
| FY 2024 | $1.53B | 64.4% | $457.0M | $312.4M | $4.36 | — |
| Q3 2024 | $378.7M | 63.9% | $133.7M | $131.1M | $1.79 | — |
| Q2 2024 | $394.1M | 64.9% | $102.7M | $62.1M | $0.88 | — |
| Q1 2024 | $370.0M | 68.1% | $100.4M | $131.1M | $1.87 | — |
| Q4 2023 | $354.0M | 64.9% | $137.5M | $103.4M | $1.47 | — |
| FY 2023 | $1.30B | 54.7% | $364.6M | $326.7M | $4.65 | — |